These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 11287761

  • 21. Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
    Oyama Y, Kazama JJ, Omori K, Higuchi N, Kameda S, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F.
    Clin Exp Nephrol; 2005 Jun; 9(2):142-7. PubMed ID: 15980949
    [Abstract] [Full Text] [Related]

  • 22. Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium.
    Graham KA, Hoenich NA, Tarbit M, Ward MK, Goodship TH.
    J Am Soc Nephrol; 1997 Apr; 8(4):627-31. PubMed ID: 10495792
    [Abstract] [Full Text] [Related]

  • 23. Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients.
    Rolla D, Paoletti E, Marsano L, Mulas D, Peloso G, Cannella G.
    Perit Dial Int; 1993 Apr; 13(2):118-21. PubMed ID: 8494932
    [Abstract] [Full Text] [Related]

  • 24. Correction of chronic metabolic acidosis in haemodialysed patients by acetate-free biofiltration does not influence parathyroid function.
    de Précigout V, Combe C, Blanchetier V, Larroumet N, Pommereau A, Potaux L, Aparicio M.
    Nephrol Dial Transplant; 1995 Apr; 10(6):821-4. PubMed ID: 7566610
    [Abstract] [Full Text] [Related]

  • 25. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H, Koiwa F, Shishido K, Takahashi K, Ito H, Kinugasa E, Taguchi S.
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [Abstract] [Full Text] [Related]

  • 26. Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease.
    Jara A, Felsenfeld AJ, Bover J, Kleeman CR.
    Kidney Int; 2000 Sep; 58(3):1023-32. PubMed ID: 10972667
    [Abstract] [Full Text] [Related]

  • 27. Effect of metabolic acidosis on branched-chain amino acids in uremia.
    Mak RH.
    Pediatr Nephrol; 1999 May; 13(4):319-22. PubMed ID: 10454782
    [Abstract] [Full Text] [Related]

  • 28. Influence of rapid correction of metabolic acidosis on serum osteocalcin level in chronic renal failure.
    Lin YF, Shieh SD, Diang LK, Lin SH, Chyr SH, Li BL, Lu KC.
    ASAIO J; 1994 May; 40(3):M440-4. PubMed ID: 8555554
    [Abstract] [Full Text] [Related]

  • 29. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S, Wazny LD, Martin JE.
    Can J Clin Pharmacol; 2008 May; 15(1):e36-43. PubMed ID: 18192704
    [Abstract] [Full Text] [Related]

  • 30. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 31. Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride.
    Sonikian MA, Pani IT, Iliopoulos AN, Koutala KG, Marioli SI, Vlassopoulos DA.
    Ren Fail; 2005 Apr; 27(2):143-7. PubMed ID: 15807177
    [Abstract] [Full Text] [Related]

  • 32. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
    Kurz P, Tsobanelis T, Brunkhorst R, Roth P, Werner E, Schoeppe W, Vlachojannis J.
    Perit Dial Int; 1997 Apr; 17(1):59-65. PubMed ID: 9068024
    [Abstract] [Full Text] [Related]

  • 33. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [Abstract] [Full Text] [Related]

  • 34. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol.
    Cannella G, Bonucci E, Rolla D, Ballanti P, Moriero E, De Grandi R, Augeri C, Claudiani F, Di Maio G.
    Kidney Int; 1994 Oct; 46(4):1124-32. PubMed ID: 7861707
    [Abstract] [Full Text] [Related]

  • 35. Effects of oral base therapy on serum ionized calcium, phosphorus and parathyroid hormone in chronic hemodialysis patients.
    Caruana RJ, Weinstein RS, Campbell HT, Chaudhary BA, Smith KL, Kurunsaari KM.
    Int J Artif Organs; 1989 Dec; 12(12):778-81. PubMed ID: 2559040
    [Abstract] [Full Text] [Related]

  • 36. Substitution of calcium carbonate for aluminum hydroxide in patients on hemodialysis. Effects on acidosis, on parathyroid function, and on calcemia.
    Anelli A, Brancaccio D, Damasso R, Padovese P, Gallieni M, Garella S.
    Nephron; 1989 Dec; 52(2):125-32. PubMed ID: 2500612
    [Abstract] [Full Text] [Related]

  • 37. Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk.
    Harris DC, Yuill E, Chesher DW.
    J Am Soc Nephrol; 1995 Dec; 6(6):1607-12. PubMed ID: 8749687
    [Abstract] [Full Text] [Related]

  • 38. Effect of metabolic acidosis on hyperlipidemia in uremia.
    Mak RH.
    Pediatr Nephrol; 1999 Nov; 13(9):891-3. PubMed ID: 10603143
    [Abstract] [Full Text] [Related]

  • 39. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J, Niemczyk S, Przedlacki J, Puka J, Switalski M, Ostrowski K.
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [Abstract] [Full Text] [Related]

  • 40. Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis.
    Chen L, He JX, Chen YY, Ling YS, Lin CH, Guan TJ.
    Ren Fail; 2018 Nov; 40(1):15-21. PubMed ID: 29295646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.